{"id":69005,"date":"2026-03-13T11:51:26","date_gmt":"2026-03-13T11:51:26","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69005"},"modified":"2026-05-21T07:14:11","modified_gmt":"2026-05-21T07:14:11","slug":"cjc-1295-without-dac","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/cjc-1295-without-dac\/","title":{"rendered":"CJC-1295 f\u0103r\u0103 DAC"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u0103spuns rapid \u2014 Ce este CJC-1295 f\u0103r\u0103 DAC?<\/h3>\n<p style=\"margin: 0;\"><strong>CJC-1295 f\u0103r\u0103 DAC<\/strong> (de asemenea numit <strong>Mod GRF 1-29<\/strong>) este un analog sintetic modificat al GHRH (1-29) cu o semivid\u0103 plasmatic\u0103 scurt\u0103 de ~30 de minute. Spre deosebire de versiunea cu DAC, acesta nu are leg\u0103tura de legare a albuminei, produc\u00e2nd un <strong>pulsatoriu<\/strong> mai degrab\u0103 dec\u00e2t un semnal GH sus\u021binut. Acest profil cinetic \u00eel face instrumentul de cercetare preferat atunci c\u00e2nd momentul pulsului conteaz\u0103. Furnizat \u00een flacoane liofilizate de la 2 mg p\u00e2n\u0103 la 10 mg, destinat exclusiv utiliz\u0103rii \u00een laborator.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Peptide liofilizate pentru cercetare \u00b7 puritate HPLC \u226599% (certificat de analiz\u0103 la cerere) \u00b7 Ambalaj discret stabil la temperatur\u0103 \u00b7 Curierat worldwide de peptide \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifica\u021bii<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detaliu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u0103r CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">863288-34-0 (p\u0103rinte) \u00b7 446262-90-4 (forma Mod-GRF 1\u201329 larg citat\u0103)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>152<\/sub>H<sub>252<\/sub>N<sub>44<\/sub>O<sub>42<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Greutate molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">3367.92 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secven\u021b\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-Tyr-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH<sub>2<\/sub> (Mod-GRF 1\u201329, f\u0103r\u0103 leg\u0103tur\u0103 DAC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pulbere liofilizat\u0103 (sau a\u0219a cum este furnizat)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puritate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificat prin HPLC, COA la cerere)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Depozitare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizat: 2\u20138\u00b0C (frigider) pentru stocul de lucru; \u221220\u00b0C pentru depozitarea pe termen lung a vialelor nefolosite. Reconstituit: 2\u20138\u00b0C, utilizat \u00een ~30 de zile. Proteja\u021bi de lumin\u0103. Nu \u00eenghe\u021ba\u021bi-decongela\u021bi solu\u021bia reconstituit\u0103.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilitate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ap\u0103 bacteriostatic\u0103 (recomandat\u0103) sau ap\u0103 steril\u0103 pentru perioade mai scurte de utilizare<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Utilizare \u00een cercetare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Doar pentru utilizare \u00een cercetare de laborator. Nu este destinat pentru uz diagnostic sau terapeutic uman sau veterinar.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Ce este CJC-1295 f\u0103r\u0103 DAC?<\/h2>\n<p><strong>CJC-1295 f\u0103r\u0103 DAC<\/strong> (denumit \u00een mod obi\u0219nuit <strong>Mod GRF 1-29<\/strong> sau pur \u0219i simplu <strong>GRF 1-29 tetrasubstitut<\/strong>) este un analog sintetic de 30 de aminoacizi al hormonului de eliberare a hormonului de cre\u0219tere. Acesta \u00eemp\u0103rt\u0103\u0219e\u0219te aceea\u0219i secven\u021b\u0103 peptidic\u0103 central\u0103 ca \u0219i <a href=\"https:\/\/medsbase.com\/ro\/cjc-1295-with-dac\/\">CJC-1295 cu DAC<\/a> \u2014 patru substitu\u021bii de aminoacizi pe secven\u021ba nativ\u0103 GHRH (1-29) confer\u0103 rezisten\u021b\u0103 la clivarea DPP-IV \u2014 dar <strong>\u00eei lipse\u0219te modificarea DAC de legare a albuminei<\/strong> care prelunge\u0219te timpul de \u00eenjum\u0103t\u0103\u021bire \u00een versiunea \u201ccu DAC\u201d.<\/p>\n<p>Consecin\u021ba practic\u0103 a absen\u021bei DAC: timpul de \u00eenjum\u0103t\u0103\u021bire \u00een plasm\u0103 r\u0103m\u00e2ne \u00een intervalul de minute-ore (~30 de minute) \u0219i nu de zile. Prin urmare, protocoalele de cercetare utilizeaz\u0103 injec\u021bii multiple zilnice (de obicei 2\u20133x) pentru a men\u021bine semnalul GHRH, \u00een locul administr\u0103rii s\u0103pt\u0103m\u00e2nale a versiunii cu DAC. Acest lucru imit\u0103 profilul scurt \u0219i pulsatoriu al GHRH endogen \u0219i este instrumentul de cercetare preferat atunci c\u00e2nd momentul pulsului conteaz\u0103 \u2014 \u00een special \u00een protocoalele care studiaz\u0103 pulsativitatea fiziologic\u0103 a GH \u00eempreun\u0103 cu agonii receptorului de ghrelin\u0103, cum ar fi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin\/\">ipamorelin<\/a>.<\/p>\n<p>Greutate molecular\u0103 aproximativ 3.367 Da. Furnizat sub form\u0103 de pulbere liofilizat\u0103 de \u00eenalt\u0103 puritate pentru reconstituire cu ap\u0103 bacteriostatic\u0103. CJC-1295 f\u0103r\u0103 DAC este <strong>destinat doar pentru cercetare de laborator<\/strong> \u0219i nu este destinat pentru diagnostic sau terapie uman\u0103 sau veterinar\u0103. Pentru mecanism, context de cercetare \u0219i protocoale de stivuire, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 research guide<\/a>.<\/p>\n<h2>Mecanism de ac\u021biune \u2014 Semnalizarea pulsatorie GHRH<\/h2>\n<p>Mod GRF 1-29 ac\u021bioneaz\u0103 prin aceea\u0219i cale a receptorului GHRH hipofizar ca \u0219i GHRH nativ, dar cu un profil cinetic care \u00eel distinge at\u00e2t de GHRH nativ, c\u00e2t \u0219i de versiunea DAC:<\/p>\n<ul>\n<li><strong>agonismul receptorului GHRH<\/strong> \u2014 CJC-1295 f\u0103r\u0103 DAC se leag\u0103 de receptorii GHRH de pe somatotrofele hipofizare, stimul\u00e2nd sinteza \u0219i eliberarea hormonului de cre\u0219tere. Substitu\u021biile de aminoacizi rezist\u0103 la degradarea DPP-IV, oferind o activitate mai lung\u0103 dec\u00e2t GHRH nativ (care dureaz\u0103 doar c\u00e2teva minute), dar totu\u0219i \u00een intervalul scurt de timp de \u00eenjum\u0103t\u0103\u021bire de 30 de minute.<\/li>\n<li><strong>Cinetic\u0103 scurt\u0103 \u0219i pulsatorie<\/strong> \u2014 deoarece nu exist\u0103 o leg\u0103tur\u0103 cu albumina, nivelurile plasmatice cresc \u0219i scad pe o scal\u0103 de timp care corespunde arhitecturii naturale a pulsului GH al organismului. Aceasta este distinc\u021bia mecanic\u0103 critic\u0103 fa\u021b\u0103 de versiunea DAC, care produce o elevare sus\u021binut\u0103 \u0219i non-pulsatorie.<\/li>\n<li><strong>Sinergie GHRP prin receptor paralel<\/strong> \u2014 co-administrarea cu un peptid de eliberare a hormonului de cre\u0219tere, cum ar fi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin\/\">ipamorelin<\/a> (ac\u021bion\u00e2nd pe calea paralel\u0103 a receptorului de ghrelin\u0103), produce pulsa\u021bii GH substan\u021bial mai mari dec\u00e2t oricare dintre compu\u0219i singuri. Versiunea cu timp de \u00eenjum\u0103t\u0103\u021bire scurt este adesea preferat\u0103 pentru aceast\u0103 cercetare de stivuire, deoarece ambele peptide pot fi sincronizate \u00eempreun\u0103 pentru amplificarea aceluia\u0219i puls.<\/li>\n<\/ul>\n<p>Implica\u021bia cercet\u0103rii: Mod GRF 1-29 este instrumentul de alegere atunci c\u00e2nd \u00eentrebarea de cercetare implic\u0103 <em>semnalizarea fiziologic\u0103 pulsatorie a GH<\/em>. Versiunea DAC este preferat\u0103 atunci c\u00e2nd \u00eentrebarea implic\u0103 <em>elevare sus\u021binut\u0103 a GH\/IGF-1<\/em>. Aceea\u0219i familie de peptide; farmacocinetic\u0103 fundamental diferit\u0103.<\/p>\n<h2>Aplica\u021bii de Cercetare Publicate<\/h2>\n<p>CJC-1295 f\u0103r\u0103 DAC este utilizat \u00een contexte de cercetare de laborator care investigheaz\u0103:<\/p>\n<ul>\n<li><strong>Eliberare pulsatorie de GH<\/strong> \u2014 cercetarea pulsului fiziologic de GH care corespunde cineticii native GHRH<\/li>\n<li><strong>combinarea Ipamorelin<\/strong> \u2014 combina\u021bia canonic\u0103 de cercetare GHRH + GHRP, folosind adesea varianta cu timp de \u00eenjum\u0103t\u0103\u021bire scurt pentru sincronizarea aceluia\u0219i puls<\/li>\n<li><strong>Cercetarea compozi\u021biei corporale<\/strong> \u2014 cercetarea masei magre, r\u0103spunsul IGF-1 \u0219i compozi\u021bia corporal\u0103 \u00een studiile de modulare pulsatorie a axei GH<\/li>\n<li><strong>Arhitectura somnului<\/strong> \u2014 dozarea \u00eenainte de somn aliniat\u0103 cu cercetarea nocturn\u0103 endogen\u0103 a GH<\/li>\n<li><strong>Cercetare de recuperare<\/strong> \u2014 protocoale de recuperare a mu\u0219chilor scheletici combinate cu <a href=\"https:\/\/medsbase.com\/ro\/bpc-157\/\">BPC-157<\/a> \u0219i <a href=\"https:\/\/medsbase.com\/ro\/tb-500\/\">TB-500<\/a> pentru cercetarea \u021besutului conjunctiv \u0219i muscular<\/li>\n<li><strong>Cercetare cinetic\u0103 comparativ\u0103<\/strong> \u2014 \u00een paralel cu <a href=\"https:\/\/medsbase.com\/ro\/cjc-1295-with-dac\/\">CJC-1295 cu DAC<\/a> pentru a izola efectul leg\u0103turii cu albumina pe semnalizarea axei GH<\/li>\n<li><strong>Compara\u021bii ale analogilor GHRH<\/strong> \u2014 al\u0103turi de <a href=\"https:\/\/medsbase.com\/ro\/sermorelin-peptide-guide\/\">sermorelin<\/a> \u0219i <a href=\"https:\/\/medsbase.com\/ro\/tesamorelin-peptide-guide\/\">tesamorelin<\/a> pentru cercet\u0103ri farmacologice inter-analoge<\/li>\n<\/ul>\n<p>Pentru un context mai larg privind peptidele din axa GH, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/peptides\/\">de peptide de cercetare<\/a>.<\/p>\n<h2>Concentra\u021bii \u0219i doze disponibile<\/h2>\n<p>MedsBase de\u021bine CJC-1295 f\u0103r\u0103 DAC \u00een urm\u0103toarele dimensiuni de flacoane liofilizate:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Putere flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caz de utilizare tipic<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensiuni pachet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Doze pilot, titrare sau protocoale scurte<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 sau 20 flacoane<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Concentra\u021bie standard de cercetare \u2014 suport\u0103 ~50 de administr\u0103ri la 100 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 sau 20 flacoane<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoale extinse, doze multiple zilnice, cel mai mic cost pe mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 sau 20 flacoane<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Deoarece Mod GRF 1-29 este de obicei administrat de 2\u20133 ori pe zi la 100\u2013200 mcg pe administrare, un flacon de 5 mg sus\u021bine 2\u20133 s\u0103pt\u0103m\u00e2ni de utilizare \u00een cercetare. Toate concentra\u021biile sunt furnizate sub form\u0103 de pulbere liofilizat\u0103 cu o puritate HPLC de 99%+.<\/p>\n<h2>Cum se compar\u0103 \u2014 CJC-1295 f\u0103r\u0103 DAC vs cu DAC vs Ipamorelin<\/h2>\n<p>Cele trei peptide ale axei GH difer\u0103 semnificativ \u00een ceea ce prive\u0219te receptorul, timpul de \u00eenjum\u0103t\u0103\u021bire \u0219i caracteristicile de stiv\u0103uire:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criteriu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 f\u0103r\u0103 DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 cu DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Clas\u0103<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analog GHRH (timp scurt de \u00eenjum\u0103t\u0103\u021bire)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analog GHRH (timp prelungit de \u00eenjum\u0103t\u0103\u021bire)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (receptor de ghrelin\u0103)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Timp de \u00eenjum\u0103t\u0103\u021bire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30 de minute<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 zile (legat de albumin\u0103)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 ore<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Profil GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulsatil, fiziologic<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cre\u0219tere sus\u021binut\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Explozie pulsatil\u0103<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Doza tipic\u0103<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013200 mcg, de 2\u20133 ori pe zi<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132 mg s\u0103pt\u0103m\u00e2nal<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300 mcg, de 2\u20133 ori pe zi<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Utilizare ideal\u0103 \u00een cercetare<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cercetare de sincronizare a pulsului, stiv\u0103uire \u00een acela\u0219i puls<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cercetare IGF-1 sus\u021binut\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u00cembinarea canonic\u0103 cu CJC-1295<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Compara\u021bie complet\u0103 a protocolului \u00een <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\">Ghidul de cercetare Ipamorelin + CJC-1295<\/a>.<\/p>\n<h2>Depozitare \u0219i reconstituire<\/h2>\n<p><strong>\u00cenainte de reconstituire:<\/strong> p\u0103stra\u021bi flacoanele liofilizate la frigider la 2\u20138\u00b0C \u00een ambalajul original, stabile p\u00e2n\u0103 la 36 de luni. Evita\u021bi ciclurile de \u00eenghe\u021b-dezghe\u021b pe pulbere.<\/p>\n<p><strong>Procedura de reconstituire:<\/strong> injecta\u021bi ap\u0103 bacteriostatic\u0103 pe peretele lateral al flaconului de peptid\u0103 conform graficului de mai sus. \u00cenv\u00e2rti\u021bi u\u0219or \u2014 nu <strong>prime\u0219te,<\/strong> zg\u00e2l\u021b\u00e2i\u021bi \u2014 \u0219i a\u0219tepta\u021bi 5\u201310 minute pentru dizolvare complet\u0103. Solu\u021bia trebuie s\u0103 fie clar\u0103 \u0219i incolor\u0103.<\/p>\n<p><strong>Dup\u0103 reconstituire:<\/strong> p\u0103stra\u021bi la frigider la 2\u20138 \u00b0C \u0219i utiliza\u021bi \u00een termen de 30 de zile. Nu \u00eenghe\u021ba\u021bi solu\u021bia reconstituit\u0103.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>Pentru ce este utilizat CJC-1295 f\u0103r\u0103 DAC \u00een cercetare?<\/h3>\n<p>CJC-1295 f\u0103r\u0103 DAC (Mod GRF 1-29) este utilizat \u00een cercetarea de laborator care investigheaz\u0103 eliberarea pulsatoare a hormonului de cre\u0219tere, farmacologia receptorului GHRH, cinetica r\u0103spunsului IGF-1, arhitectura somnului, compozi\u021bia corporal\u0103 \u0219i stiv\u0103uirea sinergic\u0103 cu peptide GHRP precum ipamorelin. Acesta este <strong>prime\u0219te,<\/strong> aprobat de FDA \u0219i este v\u00e2ndut aici strict pentru uz \u00een cercetare de laborator.<\/p>\n<h3>Care este diferen\u021ba dintre CJC-1295 cu \u0219i f\u0103r\u0103 DAC?<\/h3>\n<p>Ambele versiuni au aceea\u0219i secven\u021b\u0103 de baz\u0103 modificat\u0103 GHRH (1-29). Versiunea \u201ccu DAC\u201d are un grup maleimid care se leag\u0103 covalent de albumina seric\u0103, prelungind timpul de \u00eenjum\u0103t\u0103\u021bire \u00een plasm\u0103 de la ~30 de minute la ~7 zile. Versiunea \u201cf\u0103r\u0103 DAC\u201d nu are aceast\u0103 leg\u0103tur\u0103 \u0219i p\u0103streaz\u0103 timpul scurt de \u00eenjum\u0103t\u0103\u021bire necesar pentru protocoalele de cercetare pulsatoare. Alegerea depinde de faptul dac\u0103 \u00eentrebarea de cercetare necesit\u0103 semnalizare GHRH sus\u021binut\u0103 sau pulsatoare.<\/p>\n<h3>Care este doza tipic\u0103 de cercetare?<\/h3>\n<p>Protocoalele preclinice publicate utilizeaz\u0103 \u00een mod obi\u0219nuit 100\u2013200 mcg pe administrare, de 2\u20133 ori pe zi. Un flacon de 5 mg reconstituit cu 2,0 mL ap\u0103 bacteriostatic\u0103 ofer\u0103 o concentra\u021bie de 2,5 mg\/mL \u2014 4 grada\u021bii pe o sering\u0103 U-100 furnizeaz\u0103 100 mcg.<\/p>\n<h3>Este CJC-1295 f\u0103r\u0103 DAC aprobat de FDA?<\/h3>\n<p>Nu. Nici versiunea cu DAC, nici cea f\u0103r\u0103 DAC a CJC-1295 nu a primit aprobare de la FDA, EMA sau orice alt organism de reglementare. Dezvoltarea ini\u021bial\u0103 de c\u0103tre ConjuChem a fost \u00eentrerupt\u0103. Tot CJC-1295 v\u00e2ndut de furnizori pentru uz exclusiv \u00een cercetare este destinat doar investiga\u021biilor de laborator.<\/p>\n<h3>De ce a\u0219 alege varianta \u201cf\u0103r\u0103 DAC\u201d \u00een loc de \u201ccu DAC\u201d \u00een cercetare?<\/h3>\n<p>\u201cF\u0103r\u0103 DAC\u201d este preferat\u0103 atunci c\u00e2nd \u00eentrebarea de cercetare implic\u0103 semnalizarea fiziologic\u0103 pulsatorie a GH, stivuirea sincron\u0103 cu ipamorelin (ambele peptide administrate \u00een acela\u0219i timp) sau cercetarea arhitecturii somnului unde administrarea \u00eenainte de somn trebuie s\u0103 coincid\u0103 cu cre\u0219terea nocturn\u0103 natural\u0103 a GH. \u201cCu DAC\u201d este preferat\u0103 pentru cercetarea privind cre\u0219terea sus\u021binut\u0103 a IGF-1 \u0219i pentru administrarea simplificat\u0103 s\u0103pt\u0103m\u00e2nal\u0103.<\/p>\n<h3>Cum ar trebui depozitat CJC-1295 f\u0103r\u0103 DAC?<\/h3>\n<p>Viale liofilizate: p\u0103strate la frigider la 2\u20138 \u00b0C \u00een ambalajul original, stabile p\u00e2n\u0103 la 36 de luni. Solu\u021bie reconstituit\u0103: p\u0103strat\u0103 la frigider la 2\u20138 \u00b0C, de utilizat \u00een 30 de zile. Nu \u00eenghe\u021ba\u021bi solu\u021bia reconstituit\u0103.<\/p>\n<h3>Cum reconstitui CJC-1295 f\u0103r\u0103 DAC?<\/h3>\n<p>Urma\u021bi graficul de reconstituire de mai sus. Ad\u0103uga\u021bi ap\u0103 bacteriostatic\u0103 pe peretele lateral al flaconului, amesteca\u021bi u\u0219or \u0219i l\u0103sa\u021bi 5\u201310 minute pentru dizolvare complet\u0103. Nu <strong>prime\u0219te,<\/strong> agita\u021bi.<\/p>\n<h3>Ar trebui s\u0103 stivuesc CJC-1295 f\u0103r\u0103 DAC cu ipamorelin?<\/h3>\n<p>Da \u2014 aceasta este combina\u021bia canonic\u0103 de cercetare a axei GH pentru studiul semnaliz\u0103rii pulsatorii. Ambele peptide sunt de obicei administrate \u00eempreun\u0103 de 2\u20133 ori pe zi; timpii de \u00eenjum\u0103t\u0103\u021bire scur\u021bi ai ambelor se aliniaz\u0103 astfel \u00eenc\u00e2t fiecare administrare s\u0103 produc\u0103 o eliberare sinergic\u0103 de GH \u00een acela\u0219i puls. Consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\">ghidul de cercetare pentru combina\u021bii<\/a>.<\/p>\n<h3>Ce doze stocheaz\u0103 MedsBase?<\/h3>\n<p>MedsBase ofer\u0103 CJC-1295 f\u0103r\u0103 DAC \u00een flacoane liofilizate de 2 mg, 5 mg \u0219i 10 mg. Fiecare concentra\u021bie este disponibil\u0103 \u00een pachete de 10 sau 20 de flacoane. Toate flacoanele sunt furnizate cu o puritate HPLC de 99%+, cu certificat de analiz\u0103 la cerere.<\/p>\n<h3>CJC-1295 f\u0103r\u0103 DAC provoac\u0103 efecte adverse \u00een cercetare?<\/h3>\n<p>Cercet\u0103rile preclinice publicate au raportat un profil de siguran\u021b\u0103 rezonabil la dozele tipice de cercetare. Cea mai frecvent observa\u021bie raportat\u0103 este ro\u0219ea\u021ba tranzitorie la locul inject\u0103rii. Nu sunt disponibile date privind siguran\u021ba pe termen lung la om. Deoarece cinetica pulsatorie este mai apropiat\u0103 de GHRH nativ dec\u00e2t versiunea cu DAC, unii cercet\u0103tori consider\u0103 c\u0103 aceast\u0103 form\u0103 este mai fiziologic consistent\u0103.<\/p>\n<h3>Care este timpul de \u00eenjum\u0103t\u0103\u021bire al CJC-1295 f\u0103r\u0103 DAC?<\/h3>\n<p>CJC-1295 f\u0103r\u0103 DAC (GRF(1-29) modificat) are un timp de \u00eenjum\u0103t\u0103\u021bire plasmatic de aproximativ 30 de minute \u2014 extins fa\u021b\u0103 de ~7 minute ale GHRH(1-29) nativ prin patru substitu\u021bii de aminoacizi care protejeaz\u0103 \u00eempotriva degrad\u0103rii enzimatice. Acest timp de \u00eenjum\u0103t\u0103\u021bire moderat produce un model pulsatoriu de eliberare a GH, f\u0103c\u00e2ndu-l mai similar fiziologic cu semnalizarea endogen\u0103 a GHRH dec\u00e2t forma cu DAC cu ac\u021biune mai \u00eendelungat\u0103.<\/p>\n<h3>De ce s\u0103 alegi CJC-1295 f\u0103r\u0103 DAC \u00een loc de versiunea cu DAC?<\/h3>\n<p>CJC-1295 f\u0103r\u0103 DAC p\u0103streaz\u0103 un model de secre\u021bie pulsatorie a GH similar cu fiziologia GHRH endogen\u0103. Protocoalele de cercetare care prioritizeaz\u0103 pulsatilitatea fiziologic\u0103 \u2014 \u00een special atunci c\u00e2nd sunt combinate cu un GHRP precum Ipamorelin \u2014 utilizeaz\u0103 de obicei forma f\u0103r\u0103 DAC. Versiunea cu DAC este preferat\u0103 \u00een cercet\u0103rile care necesit\u0103 o suprafa\u021b\u0103 maxim\u0103 sub curb\u0103 a GH cu administrare mai pu\u021bin frecvent\u0103.<\/p>\n<h3>Pot s\u0103 comand CJC-1295 f\u0103r\u0103 DAC pentru transport interna\u021bional?<\/h3>\n<p>Da. MedsBase expediaz\u0103 CJC-1295 f\u0103r\u0103 DAC \u00een \u00eentreaga lume prin re\u021beaua noastr\u0103 dedicat\u0103 de transport de peptide. Comenzile care con\u021bin doar peptide se calific\u0103 pentru serviciul nostru de transport independent de peptide. Comenzile sunt expediate \u00een ambalaje cu control al temperaturii \u0219i cu urm\u0103rire complet\u0103.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte peptide pentru cercetare \u00een recuperare \u0219i performan\u021b\u0103<\/h2>\n<ul>\n<li><a href=\"\/ro\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Compus de protec\u021bie corporal\u0103 \u2014 cercetare \u00een recuperarea tendonilor, ligamentelor \u0219i intestinului<\/li>\n<li><a href=\"\/ro\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Fragment de Thymosin Beta-4 \u2014 cercetare \u00een recuperarea \u021besuturilor moi \u0219i vasculare<\/li>\n<li><a href=\"\/ro\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonist selectiv de ghrelin\u0103 \u2014 puls de hormon de cre\u0219tere f\u0103r\u0103 cortizol\/prolactin\u0103<\/li>\n<li><a href=\"\/ro\/cjc-1295-with-dac\/\"><strong>CJC-1295 cu DAC<\/strong><\/a> \u2014 Analog GHRH cu timp de \u00eenjum\u0103t\u0103\u021bire prelungit<\/li>\n<li><a href=\"\/ro\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Peptid de cupru \u2014 cercetare \u00een regenerarea pielii \u0219i a \u021besutului conjunctiv<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lectur\u0103 suplimentar\u0103<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Afla\u021bi cercetarea din spatele acestui peptid<\/strong><\/p>\n<p style=\"margin: 0;\">Cititi ghidul nostru complet bazat pe dovezi: <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 mecanism, combinare \u0219i protocoale<\/strong><\/a>. Acoper\u0103 farmacologia pulsatorie vs. sus\u021binut\u0103 a GHRH, diferen\u021bele cinetice DAC vs. f\u0103r\u0103 DAC, protocoale canonice de combinare, reconstituire \u0219i note de siguran\u021b\u0103.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sus\u021bine semnalizarea de cre\u0219tere<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te reglarea metabolic\u0103<br \/>\n\u2705 Promoveaz\u0103 regenerarea \u021besuturilor<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te c\u0103ile de recuperare<br \/>\n\u2705 Stimuleaz\u0103 echilibrul hormonal<\/p>\n<p><strong>CJC-1295 cu DAC<\/strong> con\u021bine compus peptidic sintetic.<\/p>","protected":false},"featured_media":70945,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5471],"class_list":{"0":"post-69005","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-cjc-1295-without-dac","9":"first","10":"instock","11":"shipping-taxable","12":"purchasable","13":"product-type-variable","14":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/69005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=69005"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/70945"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=69005"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=69005"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=69005"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=69005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}